Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results
Por:
Westin, J, Chavez, J, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, Garcia-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A and Barba, P
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Westin, J:
MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
Chavez, J:
H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
Schuster, SJ:
Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA USA
Vucinic, V:
Univ Hosp Leipzig, Dept Hematol Cellular Therapy Hemostaseol & Infect, Leipzig, Germany
Young, PA:
Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, David Geffen Sch Med, Los Angeles, CA USA
Johnson, PC:
Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA USA
Bramanti, S:
IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Milan, Rozzano Milano, Italy
Rambaldi, A:
Univ Milan, Dept Oncol & Hematol, Bergamo, Italy
ASST Papa Giovanni XXIII, Bergamo, Italy
Meijide, JB:
Hosp Santa Creu & Sant Pau, Hematol Serv, Barcelona, Spain
Kato, K:
Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Japan
:
Hosp Germans Trias i Pujol, Clin Hematol Dept, ICO IJC, Badalona, Spain
Kwon, M:
Complutense Univ Madrid UCM, Hosp Gen Univ Gregorio Maranon, Gregorio Maranon Hlth Res Inst IiSGM, Fac Med,Dept Hematol, Madrid, Spain
Solano, C:
Hosp Clin Univ INCLIVA Valencia, Hematol Serv, Valencia, Spain
Fleming, S:
Alfred Hosp, Dept Haematol, Melbourne, Australia
Monash Univ, Australian Ctr Blood Dis, Melbourne, Australia
Dahiya, S:
Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therapy, Stanford, CA USA
Garcia-Sancho, AM:
Univ Salamanca, Hosp Univ Salamanca, Dept Hematol, IBSAL,CIBERONC, Salamanca, Spain
Ramos, PM:
Novartis Pharm AG, Basel, Switzerland
Pearson, D:
Novartis BioMed Res, Basel, Switzerland
Diallo, S:
Novartis Pharm AG, Basel, Switzerland
Zia, A:
Novartis Pharm AG, Basel, Switzerland
Segura, E:
Novartis Pharmaceut, Madrid, Spain
Masood, A:
Novartis Pharmaceut, E Hanover, NJ USA
Barba, P:
H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
Hosp Univ Vall dHebron, Dept Hematol, Barcelona, Spain
|